SIGMAFAST™ Protease Inhibitor Tablets For General Use
Inhibits serine, cysteine, aspartic, and metalloproteases.
Optimized and tested for general use.
SIGMAFAST™ Protease Inhibitor Tablets has been used to collect tracheae in combination with ice-cold radioimmunoprecipitation assay buffer in a study to determine the tracheal basal cell fate.[2] It has been used to homogenize rat lung tissues for western blot analysis.[1]
AEBSF, 2 mM
Aprotinin, 0.3 μM
Bestatin, 130 μM
EDTA, 1 mM
E-64, 14 μM
Leupeptin, 1 μM
Tableted formulation containing water-soluble protease inhibitors with broad specificity for the inhibition of serine, cysteine, and metalloproteases. Contains 4-(2-aminoethyl)benzenesu
One tablet makes 100 mL of cocktail. One mL is recommended for the inhibition of proteases equivalent to 1 mg of USP pancreatin. One tablet is recommended for the inhibition of proteases present in a maximum of 20 g of cell extract.
Tablet that is water soluble.
SIGMAFAST is a trademark of Sigma-Aldrich Co. LLC
